On option front, Maximum Call OI is at 26500 then 26200 strike while Maximum Put OI is at 25500 then 26000 strike. Call ...

Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader ...

Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...

Deciphering how the GR forms oligomers—through the binding of several subunits—opens a crucial avenue for developing more ...

Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

Amid this shift, North Carolina is emerging as an unexpected leader. After a key meeting organized by Veterans Exploring ...

Trial initiation in food allergy follows promising results in Phase 2 trial in chronic spontaneous urticaria, another IgE-driven conditionRAPT seeks to develop a differentiated anti-IgE therapy for ...

Ferguson didn't catch his only target in Sunday's 44-24 loss to the Broncos. Ferguson has been one of the league's most productive tight ends in 2025, but he laid an egg against a tough Denver defense ...

FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix's investigational intranasal potentiated oxytocin products in patients with Arginine-Vasopressin Deficien ...

Hunt (ankle/knee) does not carry an injury designation into Monday's game against the Commanders. Hunt didn't practice Thursday due to ankle and knee injuries, but he was able to log a full session ...